Prosecution Insights
Last updated: October 02, 2026
Application No. 18/698,830

PROCESS FOR ALKYL METHACRYLATE PRODUCTION

Non-Final OA §103§DOUBLEPATENT
Filed
Apr 05, 2024
Priority
Oct 08, 2021 — continuation of 63/253,564 +1 more
Examiner
WITHERSPOON, SIKARL A
Art Unit
Tech Center
Assignee
Rohm And Haas Company
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
66%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
1432 granted / 1661 resolved
+26.2% vs TC avg
Minimal -20% lift
Without
With
+-20.1%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 9m
Avg Prosecution
38 currently pending
Career history
1674
Total Applications
across all art units

Statute-Specific Performance

§101
3.4%
-36.6% vs TC avg
§103
46.2%
+6.2% vs TC avg
§102
17.1%
-22.9% vs TC avg
§112
17.3%
-22.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1661 resolved cases

Office Action

§103 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Krill et al. (US 9,963,417) in view of Krill (EP 3786148). The claims are drawn to a process for the production of alkyl methacrylate comprising: PNG media_image1.png 700 676 media_image1.png Greyscale Krill et al. teach a process for producing methyl methacrylate by reacting methacrolein with oxygen and methanol in the presence of a heterogeneous noble metal catalyst in an oxidative esterification reaction. The stationary concentration of methacrolein is less than or equal to 12% by weight based on the total weight of the reaction mixture in the reactor (abstract). The methacrolein starting material is prepared by reacting propanal with formaldehyde. According to an embodiment of the invention, the oxidative esterification reaction takes place with a molar ratio of methanol to methacrolein from 1:1 to 50:1 (col. 3, line 63 to col. 4, line 22). According to Krill et al., a mixture of methanol and methacrolein is fed into a reactor filled with a corresponding fixed bed catalyst; after reaction, the mixture is fed from the reactor to a heat exchanger where it is cooled; the cooled mixture is fed to a gas/liquid separator where the gas is continuously separated from the liquid phase; the off-gas is disposed of or recycled; the liquid phase may be neutralized, and then the reaction mixture comprising methyl methacrylate is separated from the neutralization vessel for purification, while the rest of the reaction mixture is fed back to the main reactor. In a specific example, a mixture of 30.9 wt.% of methacrolein and 69.1 wt.% of methanol is fed to a tube reactor along with a mixture of oxygen and nitrogen gas. The tube reactor contains 15g of catalyst comprising 0.9% gold, 1.1% nickel oxide on SiO2/MgO. The product mixture was analyzed by gas chromatography (col.5, line24 to col. 7, line 3). Krill et al. do not expressly teach the concentration of alcohol or methacrolein in the liquid stream exiting the reactor system, the amount of oxygen in the gas phase exiting the reactor system, or that the liquid phase stream exiting the reactor system comprising a certain concentration of an alkyl isobutyrate. However, Krill (EP 3786148) teaches a process for making methyl methacrylate by reaction of methanol and methacrolein in the presence of a nano-sized gold catalyst in slurry form, wherein the reaction output comprises isobutyric acid methyl ester (methyl isobutyrate) in an amount smaller than 1000 ppm; about 46.3% by weight of methanol, and about 9.4% by weight of methacrolein are present in the liquid stream exiting the reactor; the gas stream exiting the reactor comprises about 4.5% oxygen (0040-0058). The instant claims are rendered obvious by the combined reference teachings, since Krill teaches the same process for making methyl methacrylate that is taught by Krill et al., and teaches the reactor output not expressly taught by Krill et al., but recited by the instant claims. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-8, 10, and 12-15 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-10 of copending Application No. 18/698,828 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims are drawn to a process for producing an alkyl methacrylate by first producing methacrolein from propionaldehyde and formaldehyde, and then reacting the methacrolein with an alkyl alcohol. The difference between the instant claims and those in the reference application is that the reference application specifically make methyl methacrylate, wherein methanol is the alkyl alcohol reacted with methacrolein, while the instant claims more broadly recited the production of an alkyl methacrylate, wherein methacrolein is reacted with an alkyl alcohol. This is not a patentable distinction because the instant claims recited the use of an alkyl alcohol having from 1 to 12 carbon atoms, which includes methanol. Therefore, the instant claims are rendered obvious by claims of the reference application. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-15 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1, 2, and 5-11 of copending Application No. 18/695,395 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims are drawn to a process for producing an alkyl methacrylate by first producing methacrolein from propionaldehyde and formaldehyde, and then reacting the methacrolein with an alkyl alcohol. The difference between the instant claims and those in the reference application is that the reference application specifically make methyl methacrylate, wherein methanol is the alkyl alcohol reacted with methacrolein, while the instant claims more broadly recited the production of an alkyl methacrylate, wherein methacrolein is reacted with an alkyl alcohol. This is not a patentable distinction because the instant claims recited the use of an alkyl alcohol having from 1 to 12 carbon atoms, which includes methanol. Therefore, the instant claims are rendered obvious by claims of the reference application. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SIKARL A WITHERSPOON whose telephone number is (571)272-0649. The examiner can normally be reached M-F 9am-9pm IFP. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SIKARL A WITHERSPOON/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Apr 05, 2024
Application Filed
Aug 17, 2026
Non-Final Rejection mailed — §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741027
USE OF HIGH MOLECULAR WEIGHT HYALURONIC ACID AS OCULAR TRANSPORTING VEHICLE
3y 9m to grant Granted Sep 22, 2026
Patent 12735377
SPIN ON METAL-ORGANIC FORMULATIONS
2y 11m to grant Granted Sep 15, 2026
Patent 12735374
PREPARATION METHOD OF TRANS-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE
2y 8m to grant Granted Sep 15, 2026
Patent 12728083
1,3-BUTYLENE GLYCOL PRODUCT
4y 6m to grant Granted Sep 08, 2026
Patent 12729214
METHOD OF PRODUCING ALKENYL PHOSPHORUS COMPOUND
3y 2m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
66%
With Interview (-20.1%)
1y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1661 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month